Skip to main content

Table 3 Clinical characteristics of chronic ITP patients with IFN-γ and IFN-γR

From: The cytokine polymorphisms affecting Th1/Th2 increase the susceptibility to, and severity of, chronic ITP

 

IFN-γ AA

IFN-γ non-AA

 

IFN-γR AA

IFN-γR non-AA

 

N

(%)

N

(%)

P value

OR

95% CI

N

(%)

N

(%)

P value

OR

95% CI

No. of patients (%)

108

(85.7)

18

(14.3)

   

115

(91.3)

11

(8.7)

   

Female patients, no. of cases (%)

82

(75.9)

10

(55.6)

0.09

2.52

0.90–7.06

84

(73.0)

8

(72.7)

1.00

1.02

0.25–4.08

Age (years) at diagnosis, range (median)

2.4–81.9

(49.0)

5.0–82.3

(37.7)

0.25

  

2.4–82.3

(46.0)

19.9–79.0

(60.9)

0.20

  

Platelet count (×109/L) at diagnosis, mean ± SD

30.8

± 24.9

21.9

± 20.7

0.15

  

29.9

± 24.6

25.8

± 22.8

0.60

  

 Mild thrombocytopenia, no. of cases (%)

26

(24.1)

2

(11.1)

0.36

2.54

0.55–11.77

26

(22.6)

2

(18.2)

1.00

1.32

0.27–6.47

 Moderate thrombocytopenia, no. of cases (%)

24

(22.2)

4

(22.2)

1.00

1.00

0.30–3.32

25

(21.7)

3

(27.3)

0.71

0.74

0.18–3.00

 Severe thrombocytopenia, no. of cases (%)

35

(32.4)

5

(27.8)

0.79

1.25

0.41–3.77

37

(32.2)

3

(27.3)

1.00

1.27

0.32–5.05

 Very severe thrombocytopenia, no. of cases (%)

23

(21.3)

7

(38.9)

0.13

0.43

0.15–1.22

27

(23.5)

3

(27.3)

0.72

0.82

0.20–3.30

Minimum platelet count (×109⁄L), mean ± SD

19.4

± 18.9

12.9

± 10.7

0.045

  

18.2

± 17.6

21

± 23.1

0.63

  

Bleeding tendency, no. of cases (%)

69

(63.9)

11

(61.1)

0.80

1.13

0.40–3.14

73

(63.5)

7

(63.6)

1.00

0.99

0.28–3.59